VenomAid Diagnostics ApS: Financial statements 2021
CVR: 39981165
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
VenomAid Diagnostics ApS (CVR 39981165) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 90,000 and a net result of DKK -24,048 compared with DKK 19,520 the year before. That is an increase of 63.6% compared with the year before. The profit margin was -26.7%. Equity in the 2021 report amounted to DKK 94,376. The solvency ratio was 98.9%.
- Revenue
- DKK 90,000
- Gross Profit
- DKK 7,714
- Profit/Loss
- DKK -24,048
- Equity
- DKK 94,376
- Total Assets
- DKK 95,470
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 90 t. | 8 t. | -24 t. | 94 t. | - |
| 2020 | 55 t. | 25 t. | 20 t. | 118 t. | - |
Official annual report
Find more companies like VenomAid Diagnostics ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
VenomAid Diagnostics ApS has published its annual report for 2020. Revenue came to DKK 55,000, and the net result was DKK 19,520.
About VenomAid Diagnostics ApS
VenomAid Diagnostics ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jonas Arnold Jürgensen-Breum. The board consists of Gert Fisker Tomczyk (chair), Andreas Hougaard Laustsen-Kiel, Mads Aage Laustsen and Morten Boje Munk. The company's owners include LAUSTSEN VENTURES ApS, Moleculo Holdings ApS and Ubia Holdings ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK -867,480 and a net result of DKK -3,853,829 compared with DKK -3,694,270 the year before. Equity in the 2025 report amounted to DKK -11,289,971.